These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7286047)

  • 1. Disposition of cefoxitin in patients with ascites.
    Garcia MJ; Dominguez-Gil A; Perez FD; Rodriguez FP; Moronta FD
    Eur J Clin Pharmacol; 1981; 20(5):371-4. PubMed ID: 7286047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the transperitoneal passage of cefoxitin in the ascitic cirrhotic patient].
    Bourreille J; Le Bihan G; Beau B; Leroy A; Humbert G; Barthes PX
    Med Chir Dig; 1979; 8(7):667-70. PubMed ID: 537415
    [No Abstract]   [Full Text] [Related]  

  • 3. Disposition of cefoxitin in patients with pleural effusion.
    Barrueco M; Garcia MJ; Otero MJ; Dominguez-Gil A; de Letona JM
    Clin Ther; 1981; 3(6):425-35. PubMed ID: 7260988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of ascites on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Macias JG; Diez JL; Nieto MJ
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):57-61. PubMed ID: 7372376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefoxitin administered by i.v. infusion to patients with a pleural effusion.
    Otero MJ; Garcia MJ; Barrueco M; Dominguez-Gil A; Gomez F; Portugal Alvarez J
    Eur J Clin Pharmacol; 1984; 26(3):389-92. PubMed ID: 6734700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
    Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
    Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of acute renal impairment in the penetration of cefoxitin into interstitial tissue fluid in rabbits.
    Dominguez-Gil AA; Garcia MJ; Cepeda M; Lanao JM; Dominguez-Gil A
    Clin Ther; 1981; 3(6):413-24. PubMed ID: 7260987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of cefoperazone into ascites.
    Van Gossum A; Quenon M; Van Gossum M; Herchuelz A; Thys JP
    Eur J Clin Pharmacol; 1989; 37(6):577-80. PubMed ID: 2612553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefoxitin in patients with pleural effusion on a multiple dosage regimen.
    Garcia MJ; Otero MJ; Barrueco M; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):300-3. PubMed ID: 6746153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: relationship with TNF-alpha levels.
    Giannini E; Romagnoli P; Tenconi GL; Botta F; Malfatti F; Chiarbonello B; Mamone M; Barreca T; Testa R
    Dig Dis Sci; 2004 Feb; 49(2):275-80. PubMed ID: 15104370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic concentrations in ascitic fluid of patients with ascites and bacterial peritonitis.
    Gerding DN; Hall WH; Schierl EA
    Ann Intern Med; 1977 Jun; 86(6):708-13. PubMed ID: 869351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites.
    Yildirim B; Sari R; Isci N
    J Natl Med Assoc; 2005 Feb; 97(2):276-80. PubMed ID: 15712792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and body fluid and endometrial concentrations of cefoxitin in mares.
    Brown MP; Gronwall RR; Houston AE
    Am J Vet Res; 1986 Aug; 47(8):1734-8. PubMed ID: 3752682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolism and kinetics of ampicillin elimination in cirrhosis. Therapeutical consequences (author's transl)].
    Chalas J; Labayle D; Macarrio J; Barraud D; Lindenbaum A; Buffet C; Chaput JC
    Sem Hop; 1980 Mar 8-15; 56(9-10):464-9. PubMed ID: 6244668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].
    Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP
    Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ascitic fluid: the value of various biological tests in the differential diagnosis between cirrhotic and neoplastic ascites].
    Ghilain JM; Henrion J; Schapira M; Majois F; Beauduin M; Heller FR
    Acta Gastroenterol Belg; 1990; 53(2):168-79. PubMed ID: 2267897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of cefoxitin in the elderly.
    Garcia MJ; Garcia A; Nieto MJ; Dominguez-Gil A; Alonso G; Mellado L
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):503-9. PubMed ID: 7203727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha-related intraperitoneal release of CA 125 in cirrhotic patients with sterile ascites.
    Kalambokis G; Kostoula A; Economou M; Tsianos EV
    Clin Chem; 2005 Nov; 51(11):2207-8. PubMed ID: 16244306
    [No Abstract]   [Full Text] [Related]  

  • 19. Disposition of intravenous and intraperitoneal cefoxitin during chronic intermittent peritoneal dialysis.
    Vlasses PH; D'Silva H; Rocci ML; Koplin JR; Bland JA; Siciliano EG; Ferguson RK
    Am J Kidney Dis; 1983 Jul; 3(1):67-70. PubMed ID: 6869373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.
    Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Beauchant M
    Eur J Clin Pharmacol; 1989; 37(3):261-5. PubMed ID: 2612541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.